name	nAnno	nOverlap	fc	zscore	pvalue	adjp	or	CIl	CIu
R-HSA-8953854	Metabolism of RNA	646	216	2.42	15	5.5e-40	5e-37	3.53	2.95	4.22
R-HSA-72766	Translation	258	104	2.92	12.5	1.3e-26	5.8e-24	4.48	3.43	5.82
R-HSA-5663205	Infectious disease	326	111	2.47	10.8	2.9e-21	8.9e-19	3.42	2.67	4.35
R-HSA-72613	Eukaryotic Translation Initiation	119	58	3.53	11.1	4.1e-20	7.4e-18	6.15	4.2	9.01
R-HSA-72737	Cap-dependent Translation Initiation	119	58	3.53	11.1	4.1e-20	7.4e-18	6.15	4.2	9.01
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	111	55	3.59	11	1.5e-19	1.9e-17	6.34	4.27	9.42
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	118	57	3.5	10.9	1.5e-19	1.9e-17	6.04	4.12	8.86
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	112	55	3.56	10.9	2.5e-19	2.8e-17	6.23	4.2	9.23
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	93	49	3.82	10.9	5e-19	5.1e-17	7.17	4.65	11.1
R-HSA-927802	Nonsense-Mediated Decay (NMD)	115	55	3.47	10.6	1.2e-18	9.4e-17	5.92	4.01	8.72
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	115	55	3.47	10.6	1.2e-18	9.4e-17	5.92	4.01	8.72
R-HSA-392499	Metabolism of proteins	1907	387	1.47	9.13	1.3e-18	9.4e-17	1.82	1.59	2.07
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	95	49	3.74	10.7	1.6e-18	1.1e-16	6.86	4.47	10.5
R-HSA-192823	Viral mRNA Translation	89	47	3.83	10.7	2.4e-18	1.3e-16	7.2	4.63	11.2
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	165	68	2.99	10.3	2.2e-18	1.3e-16	4.55	3.27	6.31
R-HSA-72312	rRNA processing	201	77	2.78	10.2	2.1e-18	1.3e-16	4.05	2.99	5.46
R-HSA-72689	Formation of a pool of free 40S subunits	101	50	3.59	10.5	7e-18	3.7e-16	6.31	4.17	9.56
R-HSA-168273	Influenza Viral RNA Transcription and Replication	133	58	3.16	10	3.1e-17	1.6e-15	5	3.47	7.17
R-HSA-8868773	rRNA processing in the nucleus and cytosol	191	72	2.73	9.67	7.5e-17	3.6e-15	3.93	2.87	5.34
R-HSA-69239	Synthesis of DNA	99	48	3.51	10.1	9.5e-17	4.3e-15	6.05	3.98	9.2
R-HSA-168255	Influenza Life Cycle	143	59	2.99	9.59	3.9e-16	1.7e-14	4.54	3.18	6.44
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	182	68	2.71	9.3	9.5e-16	3.9e-14	3.87	2.8	5.3
R-HSA-1430728	Metabolism	1899	374	1.43	8.27	1.1e-15	4.4e-14	1.73	1.51	1.97
R-HSA-69306	DNA Replication	108	49	3.29	9.56	1.3e-15	5e-14	5.34	3.56	7.97
R-HSA-168254	Influenza Infection	154	60	2.82	9.12	5.2e-15	1.9e-13	4.12	2.91	5.79
R-HSA-611105	Respiratory electron transport	95	44	3.36	9.23	1.5e-14	5.3e-13	5.53	3.59	8.48
R-HSA-68874	M/G1 Transition	85	41	3.49	9.24	2.1e-14	6.8e-13	5.97	3.79	9.38
R-HSA-69002	DNA Replication Pre-Initiation	85	41	3.49	9.24	2.1e-14	6.8e-13	5.97	3.79	9.38
R-HSA-69242	S Phase	138	55	2.89	8.93	2.3e-14	7.2e-13	4.27	2.96	6.1
R-HSA-69300	Removal of licensing factors from origins	73	37	3.67	9.17	5.5e-14	1.6e-12	6.57	4.02	10.7
R-HSA-68949	Orc1 removal from chromatin	71	36	3.67	9.05	1.2e-13	3.3e-12	6.57	3.99	10.8
R-HSA-69052	Switching of origins to a post-replicative state	71	36	3.67	9.05	1.2e-13	3.3e-12	6.57	3.99	10.8
R-HSA-68867	Assembly of the pre-replicative complex	68	35	3.73	9.04	1.5e-13	4e-12	6.77	4.07	11.3
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	59	32	3.93	9.03	2.4e-13	6.4e-12	7.55	4.37	13.2
R-HSA-69304	Regulation of DNA replication	76	37	3.53	8.85	2.8e-13	7.1e-12	6.06	3.74	9.79
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	243	77	2.3	8.18	3.5e-13	8.7e-12	3.01	2.25	3.99
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	51	29	4.12	8.94	6.3e-13	1.5e-11	8.38	4.64	15.4
R-HSA-72163	mRNA Splicing - Major Pathway	183	63	2.49	8.16	8.4e-13	2e-11	3.39	2.44	4.66
R-HSA-69206	G1/S Transition	124	49	2.86	8.35	8.9e-13	2.1e-11	4.19	2.85	6.12
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	55	30	3.95	8.78	1.1e-12	2.5e-11	7.64	4.33	13.6
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	80	37	3.35	8.45	2e-12	4.4e-11	5.49	3.43	8.77
R-HSA-72172	mRNA Splicing	191	64	2.43	7.97	2.2e-12	4.8e-11	3.25	2.35	4.45
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	67	33	3.57	8.44	3.6e-12	7.5e-11	6.18	3.7	10.3
R-HSA-180585	Vif-mediated degradation of APOBEC3G	54	29	3.89	8.52	4.5e-12	9e-11	7.38	4.16	13.2
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	54	29	3.89	8.52	4.5e-12	9e-11	7.38	4.16	13.2
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	75	35	3.38	8.28	5.8e-12	1.1e-10	5.58	3.43	9.04
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	86	38	3.2	8.2	5.8e-12	1.1e-10	5.05	3.2	7.93
R-HSA-453276	Regulation of mitotic cell cycle	86	38	3.2	8.2	5.8e-12	1.1e-10	5.05	3.2	7.93
R-HSA-180534	Vpu mediated degradation of CD4	52	28	3.9	8.39	9.6e-12	1.7e-10	7.41	4.13	13.4
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	52	28	3.9	8.39	9.6e-12	1.7e-10	7.41	4.13	13.4
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	76	35	3.34	8.18	9.3e-12	1.7e-10	5.44	3.35	8.8
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	66	32	3.51	8.2	1.3e-11	2.2e-10	5.99	3.57	10
R-HSA-8951664	Neddylation	235	72	2.22	7.57	1.3e-11	2.2e-10	2.85	2.12	3.81
R-HSA-5610780	Degradation of GLI1 by the proteasome	57	29	3.69	8.14	2.6e-11	4.3e-10	6.58	3.77	11.5
R-HSA-69541	Stabilization of p53	57	29	3.69	8.14	2.6e-11	4.3e-10	6.58	3.77	11.5
R-HSA-453279	Mitotic G1-G1/S phases	143	51	2.58	7.63	2.9e-11	4.7e-10	3.56	2.46	5.09
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	51	27	3.84	8.12	3.8e-11	5.9e-10	7.14	3.95	13
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	51	27	3.84	8.12	3.8e-11	5.9e-10	7.14	3.95	13
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	51	27	3.84	8.12	3.8e-11	5.9e-10	7.14	3.95	13
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	72	33	3.32	7.91	4.3e-11	6.4e-10	5.39	3.27	8.83
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	72	33	3.32	7.91	4.3e-11	6.4e-10	5.39	3.27	8.83
R-HSA-72649	Translation initiation complex formation	58	29	3.62	8.02	4.6e-11	6.6e-10	6.36	3.65	11.1
R-HSA-72702	Ribosomal scanning and start codon recognition	58	29	3.62	8.02	4.6e-11	6.6e-10	6.36	3.65	11.1
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	52	27	3.76	7.99	6.9e-11	9.4e-10	6.86	3.82	12.4
R-HSA-69610	p53-Independent DNA Damage Response	52	27	3.76	7.99	6.9e-11	9.4e-10	6.86	3.82	12.4
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	52	27	3.76	7.99	6.9e-11	9.4e-10	6.86	3.82	12.4
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	73	33	3.28	7.81	6.8e-11	9.4e-10	5.25	3.2	8.58
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	59	29	3.56	7.9	7.8e-11	1e-09	6.14	3.55	10.6
R-HSA-8939902	Regulation of RUNX2 expression and activity	59	29	3.56	7.9	7.8e-11	1e-09	6.14	3.55	10.6
R-HSA-69563	p53-Dependent G1 DNA Damage Response	66	31	3.4	7.84	7.7e-11	1e-09	5.63	3.35	9.44
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	66	31	3.4	7.84	7.7e-11	1e-09	5.63	3.35	9.44
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	56	28	3.62	7.88	9.9e-11	1.2e-09	6.35	3.61	11.2
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	56	28	3.62	7.88	9.9e-11	1.2e-09	6.35	3.61	11.2
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	63	30	3.45	7.81	1e-10	1.2e-09	5.78	3.39	9.81
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	60	29	3.5	7.78	1.3e-10	1.5e-09	5.94	3.44	10.2
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	60	29	3.5	7.78	1.3e-10	1.5e-09	5.94	3.44	10.2
R-HSA-162906	HIV Infection	184	59	2.32	7.25	1.2e-10	1.5e-09	3.03	2.18	4.19
R-HSA-4641258	Degradation of DVL	57	28	3.56	7.75	1.7e-10	1.9e-09	6.13	3.5	10.7
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	75	33	3.19	7.61	1.7e-10	1.9e-09	5	3.06	8.11
R-HSA-2262749	Cellular response to hypoxia	75	33	3.19	7.61	1.7e-10	1.9e-09	5	3.06	8.11
R-HSA-69615	G1/S DNA Damage Checkpoints	68	31	3.3	7.62	2e-10	2.2e-09	5.33	3.18	8.86
R-HSA-5678895	Defective CFTR causes cystic fibrosis	61	29	3.44	7.66	2.2e-10	2.4e-09	5.76	3.35	9.86
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	80	34	3.08	7.47	2.8e-10	3e-09	4.71	2.92	7.52
R-HSA-4641257	Degradation of AXIN	55	27	3.56	7.61	3.7e-10	3.9e-09	6.12	3.46	10.8
R-HSA-8941858	Regulation of RUNX3 expression and activity	55	27	3.56	7.61	3.7e-10	3.9e-09	6.12	3.46	10.8
R-HSA-1169091	Activation of NF-kappaB in B cells	66	30	3.29	7.48	4.2e-10	4.5e-09	5.3	3.14	8.88
R-HSA-5387390	Hh mutants abrogate ligand secretion	59	28	3.44	7.52	4.7e-10	4.8e-09	5.74	3.3	9.92
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	59	28	3.44	7.52	4.7e-10	4.8e-09	5.74	3.3	9.92
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	86	35	2.95	7.26	6.3e-10	6.4e-09	4.37	2.75	6.88
R-HSA-162909	Host Interactions of HIV factors	128	45	2.55	7.05	7.3e-10	7.4e-09	3.47	2.34	5.07
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	60	28	3.38	7.4	7.7e-10	7.6e-09	5.56	3.21	9.56
R-HSA-8953897	Cellular responses to external stimuli	493	116	1.7	6.42	1.7e-09	1.6e-08	2.01	1.6	2.5
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	51	25	3.55	7.31	1.7e-09	1.7e-08	6.1	3.37	11
R-HSA-4608870	Asymmetric localization of PCP proteins	62	28	3.27	7.18	2e-09	1.8e-08	5.23	3.04	8.91
R-HSA-195253	Degradation of beta-catenin by the destruction complex	81	33	2.95	7.06	1.9e-09	1.8e-08	4.37	2.71	6.98
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	81	33	2.95	7.06	1.9e-09	1.8e-08	4.37	2.71	6.98
R-HSA-69202	Cyclin E associated events during G1/S transition 	82	33	2.92	6.97	2.8e-09	2.6e-08	4.28	2.66	6.82
R-HSA-1640170	Cell Cycle	607	135	1.61	6.22	3.7e-09	3.4e-08	1.87	1.52	2.29
R-HSA-5358346	Hedgehog ligand biogenesis	64	28	3.17	6.97	4.7e-09	4.3e-08	4.94	2.89	8.35
R-HSA-5658442	Regulation of RAS by GAPs	68	29	3.09	6.92	5.2e-09	4.7e-08	4.72	2.81	7.86
R-HSA-351202	Metabolism of polyamines	84	33	2.85	6.8	5.7e-09	5.1e-08	4.11	2.56	6.53
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	50	24	3.48	7.03	6.2e-09	5.5e-08	5.85	3.2	10.6
R-HSA-8948751	Regulation of PTEN stability and activity	69	29	3.05	6.82	7.7e-09	6.8e-08	4.6	2.74	7.64
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	78	31	2.88	6.67	1.2e-08	1e-07	4.19	2.56	6.76
R-HSA-69481	G2/M Checkpoints	167	51	2.21	6.32	1.4e-08	1.2e-07	2.81	1.97	3.96
R-HSA-69278	Cell Cycle, Mitotic	531	119	1.62	5.91	2.1e-08	1.8e-07	1.88	1.51	2.33
R-HSA-69620	Cell Cycle Checkpoints	292	75	1.86	5.97	3.2e-08	2.7e-07	2.22	1.68	2.93
R-HSA-69275	G2/M Transition	195	55	2.04	5.89	8.3e-08	7e-07	2.51	1.8	3.48
R-HSA-72165	mRNA Splicing - Minor Pathway	52	23	3.2	6.38	8.8e-08	7.3e-07	5.02	2.76	9.01
R-HSA-8878166	Transcriptional regulation by RUNX2	80	30	2.72	6.17	9.6e-08	7.9e-07	3.81	2.33	6.13
R-HSA-453274	Mitotic G2-G2/M phases	197	55	2.02	5.8	1.2e-07	9.8e-07	2.48	1.77	3.43
R-HSA-5619084	ABC transporter disorders	81	30	2.68	6.09	1.3e-07	1.1e-06	3.73	2.29	6
R-HSA-5607764	CLEC7A (Dectin-1) signaling	96	33	2.49	5.87	2.5e-07	2e-06	3.33	2.11	5.17
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	79	29	2.66	5.93	2.7e-07	2.1e-06	3.68	2.24	5.95
R-HSA-6799198	Complex I biogenesis	55	23	3.03	6.04	3.1e-07	2.4e-06	4.55	2.53	8.04
R-HSA-163210	Formation of ATP by chemiosmotic coupling	18	12	4.83	6.51	3.8e-07	2.8e-06	12.6	4.36	40.9
R-HSA-8949613	Cristae formation	18	12	4.83	6.51	3.8e-07	2.8e-06	12.6	4.36	40.9
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	102	34	2.42	5.75	3.8e-07	2.8e-06	3.18	2.03	4.88
R-HSA-9020702	Interleukin-1 signaling	102	34	2.42	5.75	3.8e-07	2.8e-06	3.18	2.03	4.88
R-HSA-2555396	Mitotic Metaphase and Anaphase	203	55	1.96	5.55	3.6e-07	2.8e-06	2.38	1.7	3.28
R-HSA-2262752	Cellular responses to stress	425	96	1.64	5.37	3.6e-07	2.8e-06	1.88	1.47	2.39
R-HSA-4086400	PCP/CE pathway	89	31	2.52	5.78	4.1e-07	3e-06	3.39	2.11	5.36
R-HSA-5687128	MAPK6/MAPK4 signaling	89	31	2.52	5.78	4.1e-07	3e-06	3.39	2.11	5.36
R-HSA-6807070	PTEN Regulation	140	42	2.17	5.6	4.6e-07	3.4e-06	2.73	1.85	3.98
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	108	35	2.35	5.64	5.5e-07	4e-06	3.05	1.97	4.64
R-HSA-2467813	Separation of Sister Chromatids	191	52	1.97	5.43	6.3e-07	4.5e-06	2.39	1.69	3.33
R-HSA-68882	Mitotic Anaphase	202	54	1.94	5.38	7.2e-07	5.1e-06	2.33	1.66	3.22
R-HSA-2871837	FCERI mediated NF-kB activation	79	28	2.57	5.6	9.9e-07	6.9e-06	3.48	2.1	5.64
R-HSA-71291	Metabolism of amino acids and derivatives	251	63	1.82	5.26	9.8e-07	6.9e-06	2.14	1.58	2.89
R-HSA-5689603	UCH proteinases	97	32	2.39	5.51	1.1e-06	7.5e-06	3.12	1.97	4.86
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	67	25	2.7	5.6	1.2e-06	8.6e-06	3.77	2.19	6.35
R-HSA-73856	RNA Polymerase II Transcription Termination	67	25	2.7	5.6	1.2e-06	8.6e-06	3.77	2.19	6.35
R-HSA-1268020	Mitochondrial protein import	20	12	4.35	6	2e-06	1.3e-05	9.44	3.54	26.7
R-HSA-382556	ABC-family proteins mediated transport	104	33	2.3	5.33	2e-06	1.3e-05	2.95	1.88	4.54
R-HSA-5419276	Mitochondrial translation termination	86	29	2.44	5.38	2.1e-06	1.4e-05	3.22	1.98	5.15
R-HSA-5368287	Mitochondrial translation	87	29	2.42	5.3	2.7e-06	1.8e-05	3.17	1.95	5.05
R-HSA-5696398	Nucleotide Excision Repair	111	34	2.22	5.17	3.4e-06	2.2e-05	2.8	1.81	4.27
R-HSA-6782135	Dual incision in TC-NER	66	24	2.63	5.33	3.5e-06	2.3e-05	3.61	2.09	6.13
R-HSA-5389840	Mitochondrial translation elongation	84	28	2.42	5.21	4e-06	2.6e-05	3.17	1.93	5.09
R-HSA-3858494	Beta-catenin independent WNT signaling	137	39	2.06	5.01	4.9e-06	3.2e-05	2.53	1.69	3.72
R-HSA-5632684	Hedgehog 'on' state	85	28	2.39	5.14	5.2e-06	3.3e-05	3.11	1.9	4.99
R-HSA-5610787	Hedgehog 'off' state	113	34	2.18	5.05	5.2e-06	3.3e-05	2.73	1.76	4.15
R-HSA-446652	Interleukin-1 family signaling	138	39	2.05	4.96	5.9e-06	3.8e-05	2.5	1.67	3.68
R-HSA-3700989	Transcriptional Regulation by TP53	365	81	1.61	4.73	6.1e-06	3.8e-05	1.83	1.4	2.37
R-HSA-5628897	TP53 Regulates Metabolic Genes	86	28	2.36	5.06	6.7e-06	4.2e-05	3.06	1.87	4.9
R-HSA-110320	Translesion Synthesis by POLH	19	11	4.19	5.58	8.7e-06	5.4e-05	8.64	3.16	24.8
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	65	23	2.56	5.06	9.3e-06	5.7e-05	3.46	1.98	5.91
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	83	27	2.36	4.97	9.8e-06	6e-05	3.05	1.85	4.93
R-HSA-176187	Activation of ATR in response to replication stress	37	16	3.13	5.2	1.2e-05	7.1e-05	4.8	2.34	9.68
R-HSA-5696400	Dual Incision in GG-NER	41	17	3	5.15	1.2e-05	7.4e-05	4.47	2.25	8.69
R-HSA-202424	Downstream TCR signaling	98	30	2.22	4.85	1.3e-05	7.6e-05	2.79	1.75	4.37
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	54	20	2.68	4.96	1.6e-05	9.7e-05	3.71	2.02	6.66
R-HSA-202403	TCR signaling	116	33	2.06	4.6	2.6e-05	0.00015	2.52	1.62	3.83
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	310	69	1.61	4.38	2.7e-05	0.00016	1.83	1.37	2.42
R-HSA-68886	M Phase	391	83	1.54	4.34	2.7e-05	0.00016	1.73	1.33	2.22
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	74	24	2.35	4.66	3.2e-05	0.00019	3.03	1.78	5.05
R-HSA-1236975	Antigen processing-Cross presentation	88	27	2.22	4.61	3.2e-05	0.00019	2.8	1.7	4.49
R-HSA-5621481	C-type lectin receptors (CLRs)	138	37	1.94	4.46	3.7e-05	0.00021	2.32	1.54	3.43
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	84	26	2.24	4.58	3.8e-05	0.00022	2.83	1.71	4.59
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	22	11	3.62	4.93	5.4e-05	0.00031	6.29	2.47	16
R-HSA-72187	mRNA 3'-end processing	58	20	2.5	4.58	5.4e-05	0.00031	3.32	1.82	5.87
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	126	34	1.96	4.32	6.5e-05	0.00036	2.34	1.52	3.52
R-HSA-6803529	FGFR2 alternative splicing	26	12	3.34	4.79	6.7e-05	0.00037	5.39	2.27	12.6
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	10	7	5.07	5.15	7.7e-05	0.00042	14.6	3.34	87.7
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	30	13	3.14	4.7	7.6e-05	0.00042	4.81	2.14	10.5
R-HSA-110312	Translesion synthesis by REV1	16	9	4.08	4.93	8.1e-05	0.00044	8.07	2.67	25.6
R-HSA-1643685	Disease	984	176	1.3	3.91	8.9e-05	0.00048	1.41	1.18	1.68
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	31	13	3.04	4.55	0.00011	0.00061	4.54	2.04	9.83
R-HSA-191859	snRNP Assembly	52	18	2.51	4.36	0.00012	0.00064	3.34	1.77	6.1
R-HSA-194441	Metabolism of non-coding RNA	52	18	2.51	4.36	0.00012	0.00064	3.34	1.77	6.1
R-HSA-69190	DNA strand elongation	24	11	3.32	4.55	0.00015	0.00078	5.32	2.15	12.9
R-HSA-5655862	Translesion synthesis by POLK	17	9	3.84	4.68	0.00015	0.00079	7.06	2.41	21.1
R-HSA-5656121	Translesion synthesis by POLI	17	9	3.84	4.68	0.00015	0.00079	7.06	2.41	21.1
R-HSA-68962	Activation of the pre-replicative complex	32	13	2.94	4.41	0.00017	0.00087	4.3	1.95	9.21
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	11	7	4.61	4.79	0.00019	0.00096	11	2.79	51.2
R-HSA-983169	Class I MHC mediated antigen processing & presentation	365	75	1.49	3.81	2e-04	0.001	1.65	1.25	2.15
R-HSA-1632852	Macroautophagy	68	21	2.24	4.1	0.00021	0.0011	2.82	1.59	4.83
R-HSA-5619115	Disorders of transmembrane transporters	149	37	1.8	3.93	0.00021	0.0011	2.09	1.4	3.07
R-HSA-191273	Cholesterol biosynthesis	25	11	3.19	4.38	0.00023	0.0012	4.94	2.02	11.7
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	25	11	3.19	4.38	0.00023	0.0012	4.94	2.02	11.7
R-HSA-5205647	Mitophagy	29	12	3	4.31	0.00024	0.0012	4.44	1.93	9.88
R-HSA-8878159	Transcriptional regulation by RUNX3	108	29	1.95	3.95	0.00024	0.0012	2.32	1.46	3.61
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	26	11	3.07	4.22	0.00035	0.0017	4.61	1.91	10.8
R-HSA-5696395	Formation of Incision Complex in GG-NER	43	15	2.53	4.02	4e-04	0.0019	3.37	1.67	6.55
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	39	14	2.6	4.01	0.00044	0.0021	3.52	1.69	7.06
R-HSA-166208	mTORC1-mediated signalling	23	10	3.15	4.13	5e-04	0.0024	4.83	1.89	12
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	23	10	3.15	4.13	5e-04	0.0024	4.83	1.89	12
R-HSA-8852135	Protein ubiquitination	77	22	2.07	3.77	0.00052	0.0025	2.52	1.46	4.22
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	129	32	1.8	3.65	0.00055	0.0026	2.09	1.35	3.15
R-HSA-6783310	Fanconi Anemia Pathway	40	14	2.54	3.89	0.00059	0.0028	3.39	1.63	6.75
R-HSA-69186	Lagging Strand Synthesis	20	9	3.26	4.05	0.00071	0.0034	5.14	1.88	13.7
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	24	10	3.02	3.96	0.00075	0.0035	4.49	1.78	10.9
R-HSA-5358351	Signaling by Hedgehog	148	35	1.71	3.5	8e-04	0.0038	1.96	1.29	2.9
R-HSA-429914	Deadenylation-dependent mRNA decay	55	17	2.24	3.69	0.00083	0.0039	2.82	1.49	5.13
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	10	6	4.35	4.24	0.00087	0.004	9.4	2.23	45.3
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	10	6	4.35	4.24	0.00087	0.004	9.4	2.23	45.3
R-HSA-113418	Formation of the Early Elongation Complex	33	12	2.63	3.76	0.00098	0.0045	3.59	1.61	7.66
R-HSA-162587	HIV Life Cycle	101	26	1.87	3.5	0.00098	0.0045	2.19	1.34	3.47
R-HSA-72086	mRNA Capping	29	11	2.75	3.77	0.0011	0.0048	3.84	1.63	8.6
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	21	9	3.11	3.86	0.0011	0.0049	4.71	1.75	12.2
R-HSA-379726	Mitochondrial tRNA aminoacylation	14	7	3.62	3.93	0.0013	0.0059	6.27	1.87	21
R-HSA-69166	Removal of the Flap Intermediate	14	7	3.62	3.93	0.0013	0.0059	6.27	1.87	21
R-HSA-70263	Gluconeogenesis	34	12	2.56	3.64	0.0013	0.0059	3.43	1.54	7.25
R-HSA-597592	Post-translational protein modification	1353	223	1.19	3.07	0.0015	0.0065	1.28	1.09	1.5
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	39	13	2.42	3.54	0.0015	0.0068	3.14	1.48	6.36
R-HSA-447115	Interleukin-12 family signaling	58	17	2.12	3.43	0.0016	0.007	2.61	1.39	4.71
R-HSA-174414	Processive synthesis on the C-strand of the telomere	11	6	3.95	3.92	0.0017	0.0074	7.52	1.91	31.2
R-HSA-379724	tRNA Aminoacylation	35	12	2.48	3.52	0.0018	0.0076	3.28	1.48	6.88
R-HSA-8953750	Transcriptional Regulation by E2F6	35	12	2.48	3.52	0.0018	0.0076	3.28	1.48	6.88
R-HSA-73893	DNA Damage Bypass	49	15	2.22	3.42	0.0018	0.0079	2.77	1.4	5.25
R-HSA-165159	mTOR signalling	40	13	2.35	3.44	0.002	0.0086	3.03	1.43	6.09
R-HSA-69183	Processive synthesis on the lagging strand	15	7	3.38	3.69	0.0022	0.0094	5.49	1.69	17.3
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	23	9	2.84	3.53	0.0023	0.0099	4.03	1.54	10
R-HSA-5656169	Termination of translesion DNA synthesis	32	11	2.49	3.38	0.0027	0.011	3.29	1.43	7.15
R-HSA-3371511	HSF1 activation	12	6	3.62	3.64	0.003	0.013	6.27	1.67	23.5
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	28	10	2.59	3.37	0.003	0.013	3.49	1.43	7.99
R-HSA-156580	Phase II - Conjugation of compounds	109	26	1.73	3.06	0.0032	0.013	1.97	1.21	3.11
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	42	13	2.24	3.23	0.0033	0.014	2.82	1.34	5.61
R-HSA-162599	Late Phase of HIV Life Cycle	88	22	1.81	3.06	0.0035	0.014	2.1	1.23	3.46
R-HSA-73894	DNA Repair	315	61	1.4	2.91	0.0033	0.014	1.52	1.13	2.03
R-HSA-72306	tRNA processing	83	21	1.83	3.05	0.0036	0.015	2.13	1.23	3.56
R-HSA-5673001	RAF/MAP kinase cascade	243	49	1.46	2.91	0.0035	0.015	1.6	1.14	2.21
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	29	10	2.5	3.23	0.004	0.016	3.3	1.37	7.49
R-HSA-5696394	DNA Damage Recognition in GG-NER	38	12	2.29	3.18	0.0039	0.016	2.9	1.33	5.97
R-HSA-390466	Chaperonin-mediated protein folding	43	13	2.19	3.13	0.0041	0.016	2.72	1.3	5.39
R-HSA-391251	Protein folding	43	13	2.19	3.13	0.0041	0.016	2.72	1.3	5.39
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	68	18	1.92	3.04	0.0041	0.016	2.26	1.24	3.96
R-HSA-9020591	Interleukin-12 signaling	48	14	2.11	3.09	0.0042	0.017	2.59	1.28	4.96
R-HSA-1538133	G0 and Early G1	25	9	2.61	3.22	0.0045	0.018	3.53	1.37	8.5
R-HSA-180786	Extension of Telomeres	30	10	2.42	3.11	0.0053	0.021	3.14	1.31	7.04
R-HSA-73772	RNA Polymerase I Promoter Escape	30	10	2.42	3.11	0.0053	0.021	3.14	1.31	7.04
R-HSA-1257604	PIP3 activates AKT signaling	254	50	1.43	2.75	0.0053	0.021	1.55	1.11	2.13
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	35	11	2.28	3.03	0.0058	0.022	2.88	1.27	6.12
R-HSA-5684996	MAPK1/MAPK3 signaling	249	49	1.43	2.72	0.0058	0.022	1.55	1.1	2.14
R-HSA-5675221	Negative regulation of MAPK pathway	40	12	2.17	2.98	0.0061	0.024	2.69	1.24	5.48
R-HSA-73762	RNA Polymerase I Transcription Initiation	45	13	2.09	2.94	0.0063	0.024	2.55	1.23	5.01
R-HSA-3215018	Processing and activation of SUMO	10	5	3.62	3.32	0.0069	0.026	6.26	1.44	27.3
R-HSA-8868766	rRNA processing in the mitochondrion	10	5	3.62	3.32	0.0069	0.026	6.26	1.44	27.3
R-HSA-73863	RNA Polymerase I Transcription Termination	31	10	2.34	2.98	0.0069	0.026	2.99	1.25	6.65
R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	18	7	2.82	3.09	0.0074	0.028	3.99	1.31	11.3
R-HSA-156590	Glutathione conjugation	36	11	2.21	2.92	0.0073	0.028	2.76	1.22	5.83
R-HSA-6784531	tRNA processing in the nucleus	56	15	1.94	2.82	0.0074	0.028	2.3	1.18	4.26
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	27	9	2.42	2.95	0.008	0.03	3.14	1.24	7.37
R-HSA-5654738	Signaling by FGFR2	73	18	1.79	2.7	0.009	0.033	2.06	1.13	3.57
R-HSA-73776	RNA Polymerase II Promoter Escape	47	13	2	2.76	0.0093	0.034	2.4	1.16	4.68
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	47	13	2	2.76	0.0093	0.034	2.4	1.16	4.68
R-HSA-75953	RNA Polymerase II Transcription Initiation	47	13	2	2.76	0.0093	0.034	2.4	1.16	4.68
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	47	13	2	2.76	0.0093	0.034	2.4	1.16	4.68
R-HSA-1592230	Mitochondrial biogenesis	68	17	1.81	2.69	0.0095	0.035	2.1	1.13	3.7
R-HSA-8876725	Protein methylation	19	7	2.67	2.91	0.01	0.038	3.66	1.22	10.1
R-HSA-917937	Iron uptake and transport	58	15	1.87	2.67	0.01	0.038	2.19	1.13	4.04
R-HSA-9006925	Intracellular signaling by second messengers	282	53	1.36	2.47	0.011	0.039	1.46	1.06	1.99
R-HSA-3785653	Myoclonic epilepsy of Lafora	11	5	3.29	3.05	0.011	0.04	5.22	1.26	20.6
R-HSA-6790901	rRNA modification in the nucleus and cytosol	11	5	3.29	3.05	0.011	0.04	5.22	1.26	20.6
R-HSA-69298	Association of licensing factors with the pre-replicative complex	15	6	2.9	2.94	0.011	0.04	4.18	1.22	13.2
R-HSA-539107	Activation of E2F1 target genes at G1/S	24	8	2.42	2.78	0.012	0.043	3.13	1.16	7.78
R-HSA-69205	G1/S-Specific Transcription	24	8	2.42	2.78	0.012	0.043	3.13	1.16	7.78
R-HSA-70326	Glucose metabolism	81	19	1.7	2.53	0.013	0.045	1.93	1.08	3.28
R-HSA-5213460	RIPK1-mediated regulated necrosis	20	7	2.54	2.75	0.014	0.048	3.37	1.14	9.12
R-HSA-5218859	Regulated Necrosis	20	7	2.54	2.75	0.014	0.048	3.37	1.14	9.12
R-HSA-3299685	Detoxification of Reactive Oxygen Species	34	10	2.13	2.64	0.014	0.048	2.61	1.11	5.69
R-HSA-5663084	Diseases of carbohydrate metabolism	34	10	2.13	2.64	0.014	0.048	2.61	1.11	5.69
R-HSA-73884	Base Excision Repair	39	11	2.04	2.61	0.014	0.048	2.46	1.1	5.12
R-HSA-73933	Resolution of Abasic Sites (AP sites)	39	11	2.04	2.61	0.014	0.048	2.46	1.1	5.12
R-HSA-8878171	Transcriptional regulation by RUNX1	236	45	1.38	2.37	0.014	0.048	1.49	1.04	2.08
